Patent · US Expired

Matrix metalloproteinase inhibitors and method of using same

US6531499B2 · kind B2 · utility

0Cited by
18References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 23, 2001
Grant dateMar 11, 2003
Priority date—
Expiry dateJul 23, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C275/36
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Peptoid compounds of Formula I and Formula II are disclosed The compounds are useful in the treatment of matrix metalloproteinase-mediated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.